» Articles » PMID: 9397092

Pregnancy Outcomes in Women with Gestational Diabetes Compared with the General Obstetric Population

Overview
Journal Obstet Gynecol
Date 1997 Dec 16
PMID 9397092
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare pregnancy outcome in a homogeneous group of women with glucose intolerance with that of women without this disorder.

Methods: This was a retrospective cohort study of all women with singleton cephalic-presenting pregnancies delivered at University of Texas Southwestern Medical Center during the period January 1, 1991, through December 31, 1995. During this period, women were screened selectively for glucose intolerance and National Diabetes Data Group thresholds were used to diagnose gestational diabetes. Women with class A1 gestational diabetes were compared with nondiabetic women within the cohort. Effects of confounding variables were analyzed using multiple logistic regression and a matched-control comparison. Controls were matched according to ethnicity, maternal age, maternal weight, and parity.

Results: A total of 61,209 nondiabetic women with singleton cephalic pregnancies were delivered during the study period, and 874 were diagnosed with class A1 gestational diabetes. Women with class A1 gestational diabetes were significantly older, heavier, of greater parity, and more often of Hispanic ethnicity. Hypertension (17 versus 12%), cesarean delivery (30 versus 17%), and shoulder dystocia (3 versus 1%) were significantly increased (all P < .001) in these women compared with the general obstetric population. Infants born to women with class A1 gestational diabetes were significantly larger (mean birth weight 3581 +/- 616 versus 3290 +/- 546 g, P < .001), and this accounted for the increased incidence of dystocia. The attributable risk for large for gestational age (LGA) infants due to class A1 gestational diabetes was 12%.

Conclusion: The main consequence of class A1 gestational diabetes is excessive fetal size leading to increased risk of difficult labor and delivery. We estimate that approximately one of eight women with class A1 gestational diabetes mellitus delivers an LGA infant attributable to glucose intolerance.

Citing Articles

Women's perspectives to improve prenatal care for gestational diabetes: A systematic review and meta-aggregation of qualitative studies.

Feng Y, Deng Z, Sivak A, Yeung R, Nagpal T Acta Obstet Gynecol Scand. 2024; 104(2):267-287.

PMID: 39656503 PMC: 11782075. DOI: 10.1111/aogs.14973.


Multifaceted therapeutic approach via thiazolidinedione-infused magnolol in chitosan nanoparticles targeting hyperlipidemia and oxidative stress in gestational diabetes mellitus in experimental mice.

Li R Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39264385 DOI: 10.1007/s00210-024-03404-0.


Adverse pregnancy outcomes with respect to treatment modalities in women with gestational diabetes mellitus at a rural tertiary care teaching hospital.

Bailore V, Basany K, Banda M J Family Med Prim Care. 2024; 13(8):2986-2992.

PMID: 39228532 PMC: 11368366. DOI: 10.4103/jfmpc.jfmpc_1495_23.


Association of vitamin A with gestational diabetes and thyroid disorders in pregnancy and their influence on maternal, fetal, and neonatal outcomes.

Qadeer A, Ishaq M, Safi A, Akbar A, Asif S, Komel A Ther Adv Reprod Health. 2024; 18:26334941241271542.

PMID: 39220467 PMC: 11366108. DOI: 10.1177/26334941241271542.


Intensive glycaemic targets in overweight and obese individuals with gestational diabetes mellitus: clinical trial protocol for the iGDM study.

Scifres C, Battarbee A, Feghali M, Pierce S, Edwards R, Smith E BMJ Open. 2024; 14(2):e082126.

PMID: 38423770 PMC: 10910683. DOI: 10.1136/bmjopen-2023-082126.